Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 10 years
- Director since
- 2023
10 years of board service in total across 3 boards, counting each seat separately. Longest: Tarsus Pharmaceuticals Inc., 3 years.
Tarsus Pharmaceuticals Inc.
Director
RxSight Inc.
Director
LENSAR Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 17, 2023 | RxSight Inc. | Other | −694,124 | — | — |
| Aug 17, 2023 | RxSight Inc. | Other | +2,610 | — | — |
| Aug 17, 2023 | RxSight Inc. | Other | +21,248 | — | — |
| Jun 16, 2023 | Tarsus Pharmaceuticals Inc. | Option exercise | +2,000 | — | — |
| Jun 1, 2023 | RxSight Inc. | Grant or award | +5,731 | — | — |
| May 25, 2023 | LENSAR Inc. | Grant or award | +9,288 | — | — |
| May 11, 2023 | Tarsus Pharmaceuticals Inc. | Other | −215,576 | — | — |
| May 11, 2023 | RxSight Inc. | Other | −258,390 | — | — |
| May 11, 2023 | Tarsus Pharmaceuticals Inc. | Other | +41,219 | — | — |
| May 11, 2023 | RxSight Inc. | Other | +98,715 | — | — |
| Mar 15, 2023 | Tarsus Pharmaceuticals Inc. | Other | −215,575 | — | — |
| Mar 15, 2023 | Tarsus Pharmaceuticals Inc. | Other | +52,194 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.